Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations

Panagiotis Baliakas, Andreas Agathangelidis, Anastasia Hadzidimitriou, Lesley-Ann Sutton, Eva Minga, Athina Tsanousa, Lydia Scarfò, Zadie Davis, Xiao-Jie Yan, Tait Shanafelt, Karla Plevova, Yorick Sandberg, Fie Juhl Vojdeman, Myriam Boudjogra, Tatiana Tzenou, Maria Chatzouli, Charles C. Chu, Silvio Veronese, Anne Gardiner, Larry Mansouri, Karin E. Smedby, Lone Bredo Pedersen, Denis Moreno, Kirsten Van Lom, Véronique Giudicelli, Hana Skuhrova Francova, Florence Nguyen-Khac, Panagiotis Panagiotidis, Gunnar Juliusson, Lefteris Angelis, Achilles Anagnostopoulos, Marie-Paule Lefranc, Monica Facco, Livio Trentin, Mark Catherwood, Marco Montillo, Christian H. Geisler, Anton W. Langerak, Sarka Pospisilova, Nicholas Chiorazzi, David Oscier, Diane F. Jelinek, Nikos Darzentas, Chrysoula Belessi, Frederic Davi, Paolo Ghia, Richard Rosenquist, Kostas Stamatopoulos

Blood (2015) 125 (5): 856–859.

https://doi.org/10.1182/blood-2014-09-600874

Published: 2015

Includes: Supplemental data

Journal Articles

Clonal B-cell lymphocytosis exhibiting immunophenotypic features consistent with a marginal-zone origin: is this a distinct entity?

Blood (2014) 123 (8): 1199–1206.

https://doi.org/10.1182/blood-2013-07-515155

Published: 2014

Journal Articles

Mutations In XPO1, POT1, BIRC3 and FBXW7 collectively Predict Poor Outcome At Diagnosis In CLL and MBL Independent From The SF3B1 and NOTCH1 Status

Nils Winkelmann, MD, Mathew J Rose-Zerilli, PhD, Jade Forster, Mathew Parry, PhD, Anton Parker, BSc, Anne Gardiner, Zadie Davies, BSC, Andrew J Steele, PhD, Helen Parker, PhD, Andrew Collins, PhD, Nick C.P. Cross, PhD, David Oscier, MD, Jonathan C Strefford

Blood (2013) 122 (21): 4138.

https://doi.org/10.1182/blood.V122.21.4138.4138

Published: 2013

Journal Articles

The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial

David G. Oscier, Matthew J. J. Rose-Zerilli, Nils Winkelmann, David Gonzalez de Castro, Belen Gomez, Jade Forster, Helen Parker, Anton Parker, Anne Gardiner, Andrew Collins, Monica Else, Nicholas C. P. Cross, Daniel Catovsky, Jonathan C. Strefford

Blood (2013) 121 (3): 468–475.

https://doi.org/10.1182/blood-2012-05-429282

Published: 2013

Includes: Supplemental data

Journal Articles

Monoclonal B-Cell Lymphocytosis Exhibiting Immunophenotypic Features Consistent with Marginal Zone Origin: What Is This Entity?

Aliki Xochelli, Panagiotis Baliakas, Anne Gardiner, Sarah Mould, Zadie Davis, Neil McIver-Brown, Rachel Ibbotson, Evangelia Stalika, George Kanellis, Anastasia Athanasiadou, Achilles Anagnostopoulos, Theodora Papadaki, Kostas Stamatopoulos, David Oscier

Blood (2012) 120 (21): 1587.

https://doi.org/10.1182/blood.V120.21.1587.1587

Published: 2012

Journal Articles

The Correlation Between Deletion Architecture, ATM Mutational Status and BIRC3 Disruption in 11q-Deleted CLL

Matthew JJ Rose-Zerilli, PhD, Jade Forster, Helen Parker, PhD, Anton Parker, Ana E Rodríguez, Tracy Chaplin, Anne Gardiner, Andrew Collins, PhD, Bryan D Young, PhD, Tatjana Stankovic, MD., PhD, David Oscier, MD, Jonathan C. Strefford, BSc, PhD

Blood (2012) 120 (21): 658.

https://doi.org/10.1182/blood.V120.21.658.658

Published: 2012

Journal Articles

A Reappraisal of the Biological and Clinical Implications of Chromosomal Translocations in Chronic Lymphocytic Leukemia

Panagiotis Baliakas, Michalis Iskas, Anne Gardiner, Zadie Davis, Karla Plevova, Jitka Malcikova, Achilles Anagnostopoulos, Sharron Glide, Sarah Mould, Gabriela Vankova, Sarka Pospisilova, Anastasia Athanasiadou, Kostas Stamatopoulos, David Oscier

Blood (2012) 120 (21): 3915.

https://doi.org/10.1182/blood.V120.21.3915.3915

Published: 2012

Journal Articles

Polyclonal Serum FLC Levels: a Simple Risk Stratification Model for Identifying Aggressive Stage A CLL.

Guy Pratt, Alison Levoguer, Jeffrey Faint, Chris Fegan, Chris Pepper, David Graham Oscier, MD, Anne Gardiner, Stephen Harding, PhD

Blood (2010) 116 (21): 4608.

https://doi.org/10.1182/blood.V116.21.4608.4608

Published: 2010

Journal Articles

Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group

Blood (2010) 116 (9): 1479–1488.

https://doi.org/10.1182/blood-2010-02-267476

Published: 2010

Includes: Supplemental data

Journal Articles

13q Deletion Size Predicts Disease Progression and Response to Treatment in Patients with Chronic Lymphocytic Leukaemia.

Jonathan C Strefford, PhD, Helen Parker, PhD, Anton Parker, BSc, Hazel Robinson, PhD, Tracy Chaplin, MSc, Xiao-He Chen, PhD, David Bunyan, PhD, Anne Gardiner, BSc, Bryan D Young, PhD, David Graham Oscier, MD

Blood (2009) 114 (22): 671.

https://doi.org/10.1182/blood.V114.22.671.671

Published: 2009

Journal Articles

Serum FLC Levels at Presentation Have Independent Prognostic Significance in CLL and Levels Above 50mg/L Identify Patients with Progressive Disease.

Guy Pratt, Stephen Harding, PhD, Chris Fegan, Chris J Pepper, David Oscier, Anne Gardiner, Roger Holder, Arthur Bradwell, FRCP, FRCPath, Graham Mead, PhD

Blood (2009) 114 (22): 2355.

https://doi.org/10.1182/blood.V114.22.2355.2355

Published: 2009

Journal Articles

TP53 Abnormalities in Chronic Lymphocytic Leukemia Exhibit a Disease Specific Profile: Meta-Analysis of 270 Mutations.

Blood (2008) 112 (11): 2077.

https://doi.org/10.1182/blood.V112.11.2077.2077

Published: 2008

Journal Articles

A Novel Functional Assay Using Etoposide Plus Nutlin 3, FISH and Mutational Analysis Detects Heterogeneity of ATM/p53 Pathway Alterations in CLL.

Giles Best, PhD, Anne Gardiner, BSc, Rachel Ibbotson, PhD, Aneela Majid, PhD, Renata Walewska, MD, Belinda Austen, MD, Tanja Stankovic, PhD, Martin Dyer, MD, David Graham Oscier, MD

Blood (2006) 108 (11): 2795.

https://doi.org/10.1182/blood.V108.11.2795.2795

Published: 2006

Journal Articles

Defining the 10 Year Risk of Disease Progression in Stage A0 CLL.

Anne Gardiner, BSc, Zadie Davis, MSc, Parker Anton, BSc, Giles Best, PhD, Rachel Ibbotson, PhD, Sarah Mould, BSc, Sharron Glide, BSc, Peter Thomas, PhD, Jenny Orchard, MD, David Graham Oscier, MD

Blood (2006) 108 (11): 2772.

https://doi.org/10.1182/blood.V108.11.2772.2772

Published: 2006

Journal Articles

VH Gene Analysis in Splenic Marginal Zone Lymphoma Identifies Patients with Structurally Similar B Cell Receptors but Does Not Provide Prognostic Information.

David Graham Oscier, MD, Zadie Davis, MSc, Patricia Algara, MD, Alexandra Traverse-Glehen, MD, Kostos Stamatopoulos, MD, Jan Delabie, MD, Anne Gardiner, BSc, Chrysoula Belessi, MD, Nikolaos Loutaris, MD, Estella Matutes, MD, Gilles Salles, MD, Manuela Mollejo, MD, Miguel Piris, MD

Blood (2006) 108 (11): 2421.

https://doi.org/10.1182/blood.V108.11.2421.2421

Published: 2006

Journal Articles

ZAP-70 expression is associated with enhanced ability to respond to migratory and survival signals in B-cell chronic lymphocytic leukemia (B-CLL)

Sarah J. Richardson, Christine Matthews, Mark A. Catherwood, H. Denis Alexander, B. Sean Carey, Joanna Farrugia, Anne Gardiner, Sarah Mould, David Oscier, J. Adrian Copplestone, Archibald G. Prentice

Blood (2006) 107 (9): 3584–3592.

https://doi.org/10.1182/blood-2005-04-1718

Published: 2006

Journal Articles

CLL Tumours with a Deletion of 11q Form Two Functional Subgroups Based on the Mutation Status of the Remaining ATM Allele.

Belinda Austen, Maria Podinovskaia, Claire Almond, Graham Fews, Anne Gardiner, David Oscier, Paul Moss, Tanja Stankovic

Blood (2005) 106 (11): 710.

https://doi.org/10.1182/blood.V106.11.710.710

Published: 2005

Journal Articles

Unmutated Ig V H Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia

Terry J. Hamblin, Zadie Davis, Anne Gardiner, David G. Oscier, Freda K. Stevenson

Blood (1999) 94 (6): 1848–1854.

https://doi.org/10.1182/blood.V94.6.1848

Published: 1999

NARROW

Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations

Clonal B-cell lymphocytosis exhibiting immunophenotypic features consistent with a marginal-zone origin: is this a distinct entity?

Mutations In XPO1, POT1, BIRC3 and FBXW7 collectively Predict Poor Outcome At Diagnosis In CLL and MBL Independent From The SF3B1 and NOTCH1 Status

The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial

Monoclonal B-Cell Lymphocytosis Exhibiting Immunophenotypic Features Consistent with Marginal Zone Origin: What Is This Entity?

The Correlation Between Deletion Architecture, ATM Mutational Status and BIRC3 Disruption in 11q-Deleted CLL

A Reappraisal of the Biological and Clinical Implications of Chromosomal Translocations in Chronic Lymphocytic Leukemia

Polyclonal Serum FLC Levels: a Simple Risk Stratification Model for Identifying Aggressive Stage A CLL.

Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group

13q Deletion Size Predicts Disease Progression and Response to Treatment in Patients with Chronic Lymphocytic Leukaemia.

Serum FLC Levels at Presentation Have Independent Prognostic Significance in CLL and Levels Above 50mg/L Identify Patients with Progressive Disease.

TP53 Abnormalities in Chronic Lymphocytic Leukemia Exhibit a Disease Specific Profile: Meta-Analysis of 270 Mutations.

A Novel Functional Assay Using Etoposide Plus Nutlin 3, FISH and Mutational Analysis Detects Heterogeneity of ATM/p53 Pathway Alterations in CLL.

Defining the 10 Year Risk of Disease Progression in Stage A0 CLL.

VH Gene Analysis in Splenic Marginal Zone Lymphoma Identifies Patients with Structurally Similar B Cell Receptors but Does Not Provide Prognostic Information.

ZAP-70 expression is associated with enhanced ability to respond to migratory and survival signals in B-cell chronic lymphocytic leukemia (B-CLL)

CLL Tumours with a Deletion of 11q Form Two Functional Subgroups Based on the Mutation Status of the Remaining ATM Allele.

Unmutated Ig V H Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only